AbbVie Inc (NYSE:ABBV) has petitioned the U.S. Supreme Court to protect its corporate records, arguing that a lower court ruling threatens the confidentiality of attorney communications. The ...
WASHINGTON, Feb 2 (Reuters) - Federal and state regulators have challenged agreements made by Solvay SA with generic drug companies Watson Pharmaceuticals Inc , Par Pharmaceuticals and Paddock ...
(Reuters) - Perrigo Co has lost a bid to revive a lawsuit accusing AbbVie Inc of filing a "sham" patent lawsuit to block it from launching a generic version of AbbVie's testosterone replacement ...
San Francisco, Calif. and Torrance, Calif. (June 20, 2002) – A Phase 3 study conducted at multiple research centers in the U.S. under the direction of Ronald Swerdloff, MD, Principal Investigator at ...
(Reuters) - Any way you look at it, AbbVie ABBV.N predecessor Abbott Laboratories ABT.N made a bad decision when it sued generic drug maker Perrigo PRGO.N in 2011, as Perrigo geared up to bring a ...
PHILADELPHIA (CN) — The Third Circuit threw out an order Wednesday that required two drugmakers to disgorge $448 million for trying to keep generic versions of ...
A federal appeals court on Wednesday threw out an order that had required AbbVie Inc and a partner to disgorge $448 million in profit, in antitrust litigation ...
July 5 (Reuters) - A U.S. judge on Thursday overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its testosterone ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback